详情页 - 河北大学附属医院知识库

当前位置：首页 > 详情页

Nonmetastatic cell 1 gene polymorphisms are associated with the clinical progression and prognoses of patients with colorectal cancer

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of General Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. [2]Department of Gastrointestinal Surgery, Affiliated Hospital of Hebei University, Baoding, Hebei, China. [3]Department of General Surgery, Peoples Hospital of Linxi County, Xingtai, Hebei, China. [4]Department of General Surgery, Zhangjiakou First Hospital, Zhangjiakou, Hebei, China. [5]Department of Endocrinology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

出处：

DOI：

ISSN：

关键词： NME1 polymorphism colorectal cancer risk prognosis

摘要：

Genetic polymorphisms in the nonmetastatic cell 1 gene (NME1) are reportedly associated with the risk of various tumors and the prognoses of cancer patients. The aims of this study were to evaluate the contribution of two polymorphisms of NME1 to the risk of colorectal cancer (CRC) development and the clinical outcomes of CRC patients in a northern Chinese population.This study included 453 CRC patients and 464 controls. Genotyping of two polymorphisms (rs2302254 and rs16949649) in the promoter region of NME1 was performed using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.The results revealed that the rs2302254 and rs16949649 polymorphisms were not associated with the risk of CRC. However, the rs2302254 TT mutant genotype was associated with an increased risk for advanced clinical stage and lymph node metastasis. Moreover, survival analysis revealed that patients with the homozygous mutant TT genotype of rs2302254 had significantly shorter disease-free survival (DFS) and overall survival (OS) times than patients with the homozygous wild-type CC genotype.The rs2302254 polymorphism might function as a potential molecular marker for predicting the progression and prognosis of CRC.Copyright © 2025 Liu, Bai, Zhang, Xu and Kong.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2026]版：

无

最新[2025]版：

大类 | 3 区生物学

小类 | 3 区遗传学

第一作者：

第一作者机构： [1]Department of General Surgery, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]XRCC2 Arg188His polymorphism and colorectal cancer risk: a meta-analysis [2]Rs11479 in Thymidine Phosphorylase Associated with Prognosis of Patients with Colorectal Cancer Who Received Capecitabine-Based Adjuvant Chemotherapy [3]The safety and prognosis of radical surgery in colorectal cancer patients over 80 years old [4]老年男性和女性结直肠癌患者危险因素及预后对比研究 [5]Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis [6]Up-Regulated Expression of SPRY4-IT1 Predicts Poor Prognosis in Colorectal Cancer [7]Hypermethylation of the sodium channel beta subunit gene promoter is associated with colorectal cancer [8]Identification of Down-Regulated ADH1C is Associated With Poor Prognosis in Colorectal Cancer Using Bioinformatics Analysis [9]Down-regulation of miRNA-30c predicts poor prognosis in Colorectal Cancer patients [10]Overexpression of PTP1B in human colorectal cancer and its association with tumor progression and prognosis